Michael J. Mauro, MD, Memorial Sloan Kettering Cancer Center, New York, NY












Recorded on October 23, 2025





Michael J. Mauro, MD
Director, Chronic Myeloid Leukemia Program
Professor of Medicine, Leukemia Service
Memorial Sloan Kettering Cancer Center
New York, NY




Tune in for this expert-led discussion with Dr. Michael Mauro from Memorial Sloan Kettering Cancer Center on the evolving management of chronic myeloid leukemia (CML) in the era of tyrosine kinase inhibitors (TKIs) and newly approved FDA therapies. Dr. Mauro explores how TKIs have transformed prognosis, key factors guiding initial therapy selection, and best practices for managing treatment-related side effects. He also shares updates on TKI discontinuation criteria, long-term monitoring, and a forward look at ongoing trials and emerging therapeutic advances shaping the future of CML care. Gain actionable insights to enhance patient outcomes today!

Rahul Banerjee, MD, FACP, Fred Hutchinson Cancer Center, Seattle, WA












Recorded on September 25, 2025





Rahul Banerjee, MD, FACP
Assistant Professor
Fred Hutchinson Cancer Center
Seattle, WA




In this episode, Dr. Rahul Banerjee from Fred Hutchinson Cancer Center in Seattle, WA, discusses the evolving role of measurable residual disease (MRD) in hematologic malignancies. He explores what MRD is, how assays are used and interpreted, and its impact across the disease continuum. The conversation also covers MRD’s role in clinical trials, how to effectively explain MRD to patients, practical considerations for testing in community settings, and key education resources for both healthcare professionals and patients. Tune in today to gain practical insights you can apply in your daily practice!










This episode is supported by Adaptive Biotechnologies Corporation and Allogene Therapeutics.

Ann Collins, PA, Blood Cancer United, Washington, DC, Kelly Laschinger, MSN, RN, CPNP, CPHON, Blood Cancer United, Washington, DC, Sarah K. Tasian, MD, Children’s Hospital of Philadelphia, Philadelphia, PA












Recorded on September 9, 2025





Ann Collins, PA
Project Leader, Pediatric Acute Leukemia Master Clinical Trial (PedAL)
Blood Cancer United
Washington, DC





Kelly Laschinger, MSN, RN, CPNP, CPHON
Director, Clinical Trial Support Center
Blood Cancer United
Washington, DC





Sarah K. Tasian, MD
Blood Cancer United PedAL Master Clinical Trial Lead
Associate Professor of Pediatrics, University of Pennsylvania School of Medicine
Chief of Hematologic Malignancies Program, Children’s Hospital of Philadelphia
Philadelphia, PA




Join us for our first episode as Blood Cancer United! In this episode, Dr. Sarah Tasian, from Children’s Hospital of Philadelphia, and Ann Collins and Kelly Laschinger, from Blood Cancer United, join us for an in-depth discussion on pediatric acute leukemias. The conversation delves into the latest therapies, treatment challenges, and the complex realities of long-term survivorship. We also explore the groundbreaking Blood Cancer United Pediatric Acute Leukemia Master Clinical Trial (PedAL), its bold vision, global collaboration, and unified approach to data collection. Valuable clinical trial resources and strategies to support patients, families, and healthcare professionals are also shared. Tune in today!

Catherine Lai, MD, MPH, University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia, PA












Recorded on June 27, 2025





Catherine Lai, MD, MPH
Associate Professor
Physician Leader, Leukemia Clinical Research Unit
University of Pennsylvania Perelman Center for Advanced Medicine
Philadelphia, PA




In this episode, Dr. Catherine Lai, from the University of Pennsylvania’s Perelman Center for Advanced Medicine, joins us to discuss the current landscape of adult acute lymphoblastic leukemia (ALL) treatment. She highlights recent advances in frontline and relapsed therapies, the critical role of measurable residual disease (MRD), and the use of immunotherapy and targeted treatments. Dr. Lai further explores transplant considerations, management of side effects, and tailored approaches for B-cell and T-cell ALL. She also emphasizes patient-centered care, including strategies for end-of-life discussions and shared decision-making. Tune in today for expert insights and practical takeaways on the evolving future of ALL care!

Uma Borate, MBBS, MS, The Ohio State University, Columbus, OH












Recorded on May 27, 2025





Uma Borate, MBBS, MS
Associate Professor, Division of Hematology
Acute Leukemia Clinical Research Disease Group Leader
The Ohio State University
Columbus, OH




What’s changing in acute myeloid leukemia (AML)? Join Dr. Uma Borate from The Ohio State University in Columbus, Ohio, as she dives into emerging breakthroughs in AML biology, including molecular drivers, menin inhibitors, and the challenges of developing bispecifics and CAR T-cell therapies. She also shares updates from the LLS Beat AML® Master Clinical Trial and ongoing clinical trials, and reflects on the evolving treatment landscape across age groups. Don’t miss this dynamic conversation packed with expertise and hope for the future of AML!

Aaron Gerds, MD, MS, Cleveland Clinic, Cleveland, OH












Recorded on May 13, 2025





Aaron Gerds, MD, MS
Associate Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University School of Medicine
Medical Director
Case Comprehensive Cancer Center Clinical Research Office
Cleveland, OH




In this episode, Dr. Aaron Gerds from the Cleveland Clinic explores the intricacies of Myeloproliferative Neoplasms (MPNs), from diagnosis and monitoring to treatment goals and the latest therapeutic advances. Dr. Gerds discusses emerging therapies, the significance of clinical trials, strategies for managing side effects and long-term effects, and valuable resources for healthcare professionals, patients, and families. Tune in today for expert insights on MPNs!










This episode is supported by GSK plc and Karyopharm Therapeutics.

Tessa Faye Flores, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY












Recorded on April 24, 2025





Tessa Faye Flores, MD
Medical Director, Cancer Screening and Survivorship
Roswell Park Comprehensive Cancer Center
Buffalo, NY




We are pleased to celebrate the 100th episode of Treating Blood Cancers with Dr. Tessa Flores from Roswell Park Comprehensive Cancer Center in Buffalo, New York, as she shares insights into survivorship care. In this episode, Dr. Flores explores the different phases of survivorship and the psychosocial challenges that accompany each stage. She highlights the vital role of a collaborative care team, including primary care practitioners, in supporting survivors of cancer to achieve and maintain a healthy post-treatment life. As the number of survivors continues to grow, the focus on long-term wellness becomes increasingly important. Dr. Flores emphasizes, “A tenet of survivorship care is preventive care”. Tune in for this special episode and join the conversation today!










This episode is supported by Genentech, A Member of the Roche Group.







Additional Episodes on Survivorship Care:




* Key Strategies for HCPs: Supporting Caregivers and Care Partners



* Understanding Mental Health in Cancer Survivorship



* Navigating Adult Survivorship Care



* Exploring Survivorship Needs of Older Adults



* Strategic Approaches to Pediatric and AYA Survivorship Care



* Creating a Roadmap for Adult Survivorship Care



* Survivorship Care of Older Adults: Addressing the Unique Needs



* Supporting Adolescent and Young Adult (AYA) Survivors



* A Conversation on Adult Survivorship

Mikkael A. Sekeres, MD, MS, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL












Recorded on April 17, 2025





Mikkael A. Sekeres, MD, MS
Chief, Division of Hematology
Professor of Medicine
Sylvester Comprehensive Cancer Center
University of Miami
Miami, FL




Join us with Dr. Mikkael Sekeres of the University of Miami Sylvester Comprehensive Cancer Center as he explores the complexities of diagnosing and treating Myelodysplastic Syndromes (MDS), including “watch and wait.” Through case-based discussion, he highlights advances in high-risk MDS management, from novel targeted therapies to stem cell transplantation and clinical trials. Dr. Sekeres also shares strategies for managing side effects and emphasizes the importance of multidisciplinary care in improving patient outcomes. Tune in to gain valuable insights on MDS today!

Jeffrey Magee, MD, PhD, Washington University School of Medicine, St. Louis, MO












Recorded on April 3, 2025





Jeffrey Magee, MD, PhD
Elizabeth H. and James S. McDonnell III Professor of Pediatrics
Director, McDonnell Pediatric Cancer Center
Division of Pediatric Hematology and Oncology
Washington University School of Medicine
St. Louis, MO




In this episode, we sit down with Dr. Jeffrey Magee from the McDonald Pediatric Cancer Center at the Washington University School of Medicine in St. Louis to discuss the evolving landscape of pediatric blood cancers. Reflecting on his work, Dr. Magee shares, “One of the things I really love about the job is that it operates right at the interface between the science and the professional practice of medicine.” He examines groundbreaking advances bringing new hope to children and their families, from novel therapies and CAR T-cell therapy to the crucial role of clinical trials. Dr. Magee also speaks candidly about the challenges of delivering difficult news and shares compassionate strategies for supporting families through their toughest moments. Join us for this insightful and informative conversation on the future of pediatric blood cancer care today!










Additional LLS Resource:



Stars Will Twinkle, The Sun Will Shine



A three-book series and movie for kids with blood cancer. Follow Olivia and her family as she is diagnosed with leukemia, goes to the hospital for treatment, and returns to school.

Angela Dispenzieri, MD, Mayo Clinic, Rochester, MN












Recorded on March 18, 2025





Angela Dispenzieri, MD
Consultant, Division of Hematology
Serene M. and Frances C. Durling Professor of Medicine and of Laboratory
Medicine and Pathology
Mayo Clinic
Rochester, MN




Join us as we dive into in the complex care of amyloid and myeloma with Dr. Angela Dispenzieri from Mayo Clinic Rochester, Minnesota. She explains the diagnosis and explores the differences between amyloid and myeloma. Discussion on treatment strategies for complex cases, side effects of therapies, and difficult conversations with patients, provide practical information on patient care. Tune in today to learn more about the complexities of myeloma.










This episode is supported by GSK plc.

Guy Maytal, MD, Forge Health and Weill Cornell Medicine, New York












Recorded on February 20, 2025





Guy Maytal, MD
Chief Medical Officer, Forge Health
White Plains, NY
Clinical Assistant Professor of Psychiatry, Weill Cornell Medicine
New York, NY




In this episode, Dr. Guy Maytal, from Forge Health and Weill Cornell Medicine in New York, explores burnout and wellness in healthcare professionals, highlighting the difference between burnout and compassion fatigue. He shares valuable insights on recognizing these issues, while emphasizing the importance of connection, resilience, and self-care in preventing and overcoming burnout. Dr. Maytal also offers practical strategies for institutions to better support healthcare professionals. Tune in for the latest insights on healthcare professional wellness today!

Timothy Pearman, PhD, ABPP, Northwestern University Feinberg School of Medicine, Chicago, IL












Recorded on February 6, 2025





Timothy Pearman, PhD, ABPP
Director, Supportive Oncology
Robert H. Lurie Comprehensive Cancer Center
Professor, Department of Medical Social Sciences and Psychiatry & Behavioral Sciences
Northwestern University Feinberg School of Medicine
Chicago, IL




Join us for an insightful episode featuring Dr. Timothy Pearman from Northwestern University, as he explores the critical role of caregivers and care partners to a patient’s healthcare team. Dr. Pearman discusses the challenges caregivers face, including burnout, relationship stress, and issues surrounding sex and intimacy. He also offers effective communication strategies to address these challenges and shares ways healthcare professionals can better educate and support caregivers. Tune in to this informative podcast for valuable insights and resources for caregivers!










This episode is supported by Genentech, A Member of the Roche Group.

Jason Westin, M.D., MS, FACP, MD Anderson Cancer Center, Houston, TX












Recorded on January 21, 2025





Jason Westin, M.D., MS, FACP
Professor, Department of Lymphoma & Myeloma
Lead, Lymphoma & Myeloma Service Line
Director, Lymphoma Clinical Research
Section Chief, Aggressive and Indolent Lymphoma
MD Anderson Cancer Center
Houston, TX




In this episode, Dr. Jason Westin from MD Anderson Cancer Center in Houston, Texas explores CAR T-cell therapy, covering both current and emerging indications. He highlights the educational needs of patients and caregivers, as well as the essential role of community and academic collaboration before and after treatment. Dr. Westin also discusses the use of minimal/measurable residual disease (MRD) in treatment planning, future directions of CAR-T, and ongoing clinical trials. Tune in to stay up-to-date on the latest advancements in CAR T-cell therapy!










This episode is supported by Allogene Therapeutics, Bristol Myers Squibb, Johnson& Johnson & Legend Biotech, and Kite, a Gilead Company.

Jaehyuk (Jae) Choi, MD, Northwestern University Feinberg School of Medicine, Chicago, IL












Recorded on January 7, 2025





Jaehyuk (Jae) Choi, MD
Jack W. Graffin Associate Professor of Dermatology and of Biochemistry and Molecular Genetics
Northwestern University Feinberg School of Medicine
Chicago, IL




In this episode, Dr. Jaehyuk Choi from Northwestern University, explores Cutaneous T-Cell Lymphoma (CTCL), covering key diagnostic tools, emerging therapies, and the importance of a multidisciplinary team approach. He delves into effective symptom management, including the psychosocial impact of pruritus, and discusses the latest ongoing research. Additionally, Dr. Choi highlights disparities in diagnosis, treatment access, and patient outcomes. Tune in today to gain valuable insights on this complex diagnosis!










This episode is supported by Kyowa Kirin, Inc.

Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY












Recorded on December 19, 2024





Lee Greenberger, PhD
Chief Scientific Officer and SVP
The Leukemia & Lymphoma Society
Rye Brook, NY




In this episode, Lee Greenberger, PhD, Chief Scientific Officer and Senior Vice President at The Leukemia & Lymphoma Society, returns to provide information presented at the 66th American Society of Hematology (ASH) Annual Meeting, including updates in myeloma, leukemia, and lymphoma. Dr. Greenberger also discusses updates in blood cancer therapies, including nutrition, CAR T-cell therapy, and bispecifics. Tune in today!










This episode is supported by Autolus Therapeutics.

Celeste Bello, MD, Moffitt Cancer Center, Tampa, FL












Recorded on November 21, 2024





Celeste Bello, MD
Senior Member, Department of Malignant Hematology
Moffitt Cancer Center
Tampa, FL




Join us as we dive into bispecific antibodies with Dr. Celeste Bello from Moffitt Cancer Center, exploring their mechanisms of action, current indications in lymphoma, and strategies for patient selection and administration. Dr. Bello also discusses side effects, management strategies, and emerging trends in bispecific therapies. Tune in today to learn more!

Understanding Mental Health in Cancer Survivorship
















Lynn Gooden, BSN, RN, ONN-CG, Community Health Network MD Anderson Cancer Center, Indianapolis, IN and Cassie Osborne, MSN, RN, OCN, ONN-CG, Community Health Network MD Anderson Cancer Center, Indianapolis, IN












Recorded on November 14, 2024





Lynn Gooden, BSN, RN, ONN-CG
Oncology Navigation and Survivorship Manager
Oncology Navigation
Community Health Network MD Anderson Cancer Center
Indianapolis, IN





Cassie Osborne, MSN, RN, OCN, ONN-CG
Oncology Nurse Navigator
Oncology Navigation-Hematology/Sarcoma/Brain/Skin
Community Health Network MD Anderson Cancer Center
Indianapolis, IN




Join us for this important episode, as Lynn Gooden and Cassie Osborne, nurses from the Community Health Network MD Anderson Cancer Center in Indianapolis, discuss mental health challenges faced by survivors of cancer, including the impact of long-term and late effects. They explore how a multidisciplinary team can address both physical and psychosocial needs, and caregiver involvement in decision-making and support. Resources are also highlighted for healthcare professional education, along with support resources for survivors and caregivers to enhance survivorship. Tune in to today for this insightful discussion!










This episode is supported by Genentech, A Member of the Roche Group.

Kerry A. Rogers, MD, The Ohio State University, Columbus, OH












Recorded on October 29, 2024





Kerry A. Rogers, MD
Associate Professor
Division of Hematology
The Ohio State University
Columbus, OH




Tune in for this comprehensive overview of Chronic Lymphocytic Leukemia (CLL) with Dr. Kerry Rogers from The Ohio State University. She covers key risk factors, signs and symptoms, and the critical decision-making process between monitoring and initiating treatment. Also explored are treatment goals with consideration to how strategies may vary for different subsets of patients, and discussion on new therapies. Additionally, Dr. Rogers addresses side effect management and resources available to support both patients and their families. Listen to this informative episode today!

Jennifer R. Rushton, MD, Clinical Pathology Associates and the Baptist Health System, San Antonio, TX and Eric Severson, MD, PhD, Labcorp Oncology, Shelton, CT







Recorded on July 2, 2024



Join us, as we dive into the crucial topic of biomarker testing with Dr. Jennifer Rushton from Clinical Pathology Associates and the Baptist Health System, and Dr. Eric Severson from Labcorp Oncology. They explore the role of the healthcare team in integrating biomarker testing into clinical practice and decision-making, as well as strategies for effective patient communication about its importance and implications. They also share their perspectives on the future of biomarker testing. Tune in today to learn more!






Jennifer R. Rushton, MD
Clinical Pathology Associates
Medical Director, Pathology and Laboratory Medicine
Baptist Health System
San Antonio, TX









Eric Severson, MD, PhD
Executive Director Medical Affairs and Evidence Generation
Labcorp Oncology
Shelton, CT
















This episode is supported by Labcorp Oncology.

Stacie B. Dusetzina, PhD, Vanderbilt University Medical Center, Nashville, TN and Bethany Lilly, JD, The Leukemia & Lymphoma Society, Rye Brook, NY







Recorded on September 20, 2024



Tune in to this informative episode as Dr. Stacie Dusetzina from Vanderbilt University and Bethany Lilly from The Leukemia & Lymphoma Society’s Office of Public Policy simplify the complexities of Medicare, and how healthcare professionals can help their patients navigate these decisions for better care outcomes. They discuss how plan choices affect access to cancer treatment and the financial burden of high-cost medications. They also examine the recent changes brought by the Inflation Reduction Act and what they mean for Medicare beneficiaries. Listen today to learn more about helping your patients make informed decisions, including helpful resources, in this important aspect of healthcare!






Stacie B. Dusetzina, PhD
Professor, Health Policy
Ingram Professor of Cancer Research
Vanderbilt University Medical Center
Nashville, TN









Bethany Lilly, JD
Executive Director, Public Policy
The Leukemia & Lymphoma Society
Rye Brook, NY








Resources mentioned in this episode:




* American Cancer Society



* Centers for Medicare and Medicaid Services



* Medicare Plan Finder



* State Health Insurance Assistance Program (SHIP)



* The Leukemia & Lymphoma Society



* Triage Cancer